dismiss

Clean Sweep Live Auction on Wed. May 1st. Click to view the full inventory

DOTmed Home MRI Oncology Ultrasound Molecular Imaging X-Ray Cardiology Health IT Business Affairs
News Home Parts & Service Operating Room CT Women's Health Proton Therapy Endoscopy HTMs Pediatrics
SEARCH
Current Location:
>
> This Story

starstarstarstarstar (1)
Log in or Register to rate this News Story
Forward Printable StoryPrint Comment
advertisement

 

advertisement

 

Business Affairs Homepage

Canon's Vital Images wins DoD contract Maximum $100 million fixed‐price contract for radiology and imaging systems

Are you GDPR compliant? It's not just a question for EU-based companies Here are the top eight considerations

Security tightening at hospitals for patient safety A noticeable change is occurring at the front entrance to hospitals

Johnson & Johnson completes Auris Health deal The $3.4 billion acquisition could include additional payments up to $2.35 billion

Follow-up imaging study points to benefits of automated notification Raising the bar on manual callbacks

Change Healthcare files for IPO Could raise as much as $100 million, listing on Nasdaq

Mergers do nothing for quality of care, lower patient satisfaction, says study Based on 29 data points and the assessment of 16 processes of care

GE Healthcare IPO on hold as new deal takes spotlight Selling biopharma business to Danaher for over $21 billion

Asheville Radiology Association joins Strategic Radiology The latest expansion by the imaging coalition brings 43 new physicians to the table

Johnson & Johnson to acquire Auris Health for $3.4 billion With possible $2.35 billion added if certain milestones are hit

Hologic has acquired Faxitron Bioptics
for $85 million

Hologic acquires Faxitron Bioptics for $85 million

by John R. Fischer , Staff Reporter
Hologic Inc. has acquired Faxitron Bioptics for approximately $85 million, expanding its product portfolio within the breast conservation surgical market.

The purchase of the privately held enterprise gives Hologic access to Faxitron solutions, designed for breast lesion localization and sentinel lymph node biopsy, as well as digital specimen radiography.

Story Continues Below Advertisement

THE (LEADER) IN MEDICAL IMAGING TECHNOLOGY SINCE 1982. SALES-SERVICE-REPAIR

Special-Pricing Available on Medical Displays, Patient Monitors, Recorders, Printers, Media, Ultrasound Machines, and Cameras.This includes Top Brands such as SONY, BARCO, NDS, NEC, LG, EDAN, EIZO, ELO, FSN, PANASONIC, MITSUBISHI, OLYMPUS, & WIDE.



“With the expanding range of Hologic's breast health portfolio, this acquisition further strengthens our ability to positively impact patient lives by enabling us to play a larger role in breast conserving surgery, an adjacent growth market for the company's interventional breast business,” Pete Valenti, division president of Hologic’s breast and skeletal health solutions, told HCB News.

Earlier this week, Hologic scored a victory in a Delaware federal court against Minerva Surgical which it sued for patent infringement over its NovaSure Endometrial Ablation System. The court awarded the women’s health technology company $4.8 million in damages, including lost profits and $587,000 for lost sales royalties of eight percent.

The acquisition is also the second time that Faxitron has made headlines in recent weeks, having just last month merged its irradiation business with that of Precision X-ray into a new company, DRMC X-ray, which carries an installed base of more than 1,000 systems and is expected by both Faxitron and PXi to become a global leader in biological irradiation.

The agreement equips Hologic with a variety of solutions including Faxitron’s VisionCT, the first 3D breast specimen-designated CT systems designed and FDA approved to offer 360-degree images of excised lesions, and its VersaVision digital specimen radiography system, cleared in October by the FDA for imaging core biopsy and surgically excised specimen samples.

Its decision to acquire Faxitron, according to Valenti, stemmed from a shared view on innovation in breast cancer diagnostics and treatment as well as the Science of Sure approach held by Hologic to produce quality clinical results that enable early identification of symptoms, greater diagnostic confidence and compassionate treatment of patients.

“With this acquisition, Hologic can now offer our customers an increasingly comprehensive portfolio of products that offer a broad range of solutions at multiple clinical call-points including radiology, surgery and pathology,” he said.

Primarily a provider for breast surgeons and pathologists, Faxitron racked up approximately $27 million in revenue in its last fiscal year. The company's employees will not be negatively impacted by the sale, according to Hologic.

The acquisition is expected to be roughly neutral to Hologic’s non-GAAP earnings per share for the rest of fiscal 2018 and 2019, after which, it is expected to be accretive, attracting growth and return on invested capital.

Business Affairs Homepage


You Must Be Logged In To Post A Comment

Advertise
Increase Your
Brand Awareness
Auctions + Private Sales
Get The
Best Price
Buy Equipment/Parts
Find The
Lowest Price
Daily News
Read The
Latest News
Directory
Browse All
DOTmed Users
Ethics on DOTmed
View Our
Ethics Program
Gold Parts Vendor Program
Receive PH
Requests
Gold Service Dealer Program
Receive RFP/PS
Requests
Healthcare Providers
See all
HCP Tools
Jobs/Training
Find/Fill
A Job
Parts Hunter +EasyPay
Get Parts
Quotes
Recently Certified
View Recently
Certified Users
Recently Rated
View Recently
Certified Users
Rental Central
Rent Equipment
For Less
Sell Equipment/Parts
Get The
Most Money
Service Technicians Forum
Find Help
And Advice
Simple RFP
Get Equipment
Quotes
Virtual Trade Show
Find Service
For Equipment
Access and use of this site is subject to the terms and conditions of our LEGAL NOTICE & PRIVACY NOTICE
Property of and Proprietary to DOTmed.com, Inc. Copyright ©2001-2019 DOTmed.com, Inc.
ALL RIGHTS RESERVED